Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cambridge Heart expands St Jude deal:

This article was originally published in Clinica

Executive Summary

Cambridge Heart and St Jude Medical are to sell the former's HearTwave II Microvolt T-Wave Alternans test to all North American markets, following an amendment to a previous co-marketing agreement. Under the terms of the original deal, signed in March, Cambridge Heart was to target only the internal medicine and primary care markets, while St Jude would address the cardiology and electrophysiology markets. Cambridge Heart said the amendment will not have an impact on its revenue guidance for 2007.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048909

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel